The distal carboxyl terminal of rat NR3B subunit regulates NR1-1a/NR3B and NR1-2a/NR3B surface trafficking

by Wee, K.S.L., Wee, Z.-N., Chow, N.B.H., Low, C.-M.
Published 2011

PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy

by Tan, J., Li, Z., Lee, P.L., Guan, P., Aau, M.Y., Lee, S.T., Feng, M., Lim, C.Z., Lee, E.Y.J., Wee, Z.N., Lim, Y.C., Karuturi, R.K.M., Yu, Q.
Published 2014

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

by Wee, Z.N, Yatim, S.M.J.M, Kohlbauer, V.K, Feng, M, Goh, J.Y, Yi, B, Lee, P.L, Zhang, S, Wang, P.P, Lim, E, Tam, W.L, Cai, Y, Ditzel, H.J, Hoon, D.S.B, Tan, E.Y, Yu, Q
Published 2020

Erratum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel (Nature Communications (2015) 6 (8746) DOI: 10.1038/ncomms9746)

by Wee, Z.N., Yatim, S.M.J.M., Kohlabauer, V.K., Feng, M., Goh, J.Y., Bao, Y., Lee, P.L., Zhang, S., Wang, P.P., Lim, E., Tam, W.L., Cai, Y., Ditzel, H.J., Hoon, D.S.B., Tan, E.Y., Yu, Q.
Published 2020